Atlas Trials

Cilostazol 100 mg Tablet Formulations Under Fasting Conditions

Clinical trial NCT00838630 · COMPLETED

Trial details

NCT number
NCT00838630
Sponsor
Teva Pharmaceuticals USA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2003-11-01
Primary completion
2003-11-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.